Page last updated: 2024-08-23

epirubicin and Weight Loss

epirubicin has been researched along with Weight Loss in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beckmann, MW; de Gregorio, N; Fasching, PA; Fehm, T; Friedl, TWP; Harbeck, N; Jäger, B; Janni, W; Jückstock, J; Mahner, S; Mohrmann, S; Mutschler, NS; Rack, B; Salmen, J; Schochter, F; Scholz, C; Weissenbacher, T; Widschwendter, P; Ziegler, C; Zwingers, T	1
Catsoulakos, P; Karakiulakis, G; Pispirigos, K	1
Hopewell, JW; Simmonds, RH; Yeung, TK	1

Trials

1 trial(s) available for epirubicin and Weight Loss

Article	Year
Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer: Results From the ADEBAR Study. Clinical breast cancer, 2018, Volume: 18, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Germany; Humans; Kaplan-Meier Estimate; Mastectomy; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Weight Gain; Weight Loss	2018

Article

Year

Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer: Results From the ADEBAR Study.

Clinical breast cancer, 2018, Volume: 18, Issue:2

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Germany; Humans; Kaplan-Meier Estimate; Mastectomy; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Weight Gain; Weight Loss

2018

Other Studies

2 other study(ies) available for epirubicin and Weight Loss

Article	Year
Evaluation of kidney and liver subacute toxicity of antitumor agents using serum biochemical parameters in rats. Biochemistry and molecular biology international, 1993, Volume: 31, Issue:3 Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antineoplastic Agents; Aspartate Aminotransferases; Azasteroids; Blood Glucose; Chemical and Drug Induced Liver Injury; Chlorambucil; Cholesterol; Cisplatin; Epirubicin; gamma-Glutamyltransferase; Kidney; Kidney Diseases; Liver Diseases; Male; Methotrexate; Nitrogen; Nitrogen Mustard Compounds; Potassium; Rats; Rats, Wistar; Sodium; Weight Loss	1993
The relative toxicity of intravenous and intraperitoneal doses of epirubicin. Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:4 Topics: Animals; Cardiac Output; Cardiac Output, Low; Dose-Response Relationship, Drug; Epirubicin; Heart; Injections, Intraperitoneal; Injections, Intravenous; Lethal Dose 50; Male; Myocardium; Rats; Rats, Inbred Strains; Time Factors; Weight Loss	1989

Article

Year

Evaluation of kidney and liver subacute toxicity of antitumor agents using serum biochemical parameters in rats.

Biochemistry and molecular biology international, 1993, Volume: 31, Issue:3

Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antineoplastic Agents; Aspartate Aminotransferases; Azasteroids; Blood Glucose; Chemical and Drug Induced Liver Injury; Chlorambucil; Cholesterol; Cisplatin; Epirubicin; gamma-Glutamyltransferase; Kidney; Kidney Diseases; Liver Diseases; Male; Methotrexate; Nitrogen; Nitrogen Mustard Compounds; Potassium; Rats; Rats, Wistar; Sodium; Weight Loss

1993

The relative toxicity of intravenous and intraperitoneal doses of epirubicin.

Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:4

Topics: Animals; Cardiac Output; Cardiac Output, Low; Dose-Response Relationship, Drug; Epirubicin; Heart; Injections, Intraperitoneal; Injections, Intravenous; Lethal Dose 50; Male; Myocardium; Rats; Rats, Inbred Strains; Time Factors; Weight Loss

1989